On each day, participants were randomised to receive a bolus infusion of metformin (1000 mg in 50 ml 0.9% saline) via a nasoduodenal catheter at t = 60, 30 or 0 min (and saline at the other timepoints) or saline at all timepoints (control), followed by an intraduodenal glucose infusion of 12.56 kJ/min (3 kcal/min) at t = 060 min
Diabetes Care 33 , 11731175 (2010)
The intervention group consisted of patients who were prescribed GLP-1 RA medications, including Victoza (Liraglutide 1.8 mg), Saxenda (Liraglutide 3 mg), Ozempic (Semaglutide 1 mg), and Wegovy (Semaglutide 2.4 mg)
In Medicare alone, she said, GLP-1 coverage could yield $245 billion in savings over the first 10 years through reduced diabetes, cardiovascular events, and comorbidities
Each serving helps support balanced nutrition during reduced food intake